2025-08148RuleWallet

Voriconazole Test System Classified as Class II by FDA

Published Date: 5/9/2025

Rule

Summary

The FDA is officially classifying the voriconazole test system as a Class II device with special safety rules, making it safer and easier to get to patients. This change lowers regulatory hurdles, speeding up access to this important medical test without extra costs. The new classification is effective May 9, 2025, benefiting device makers and patients alike.

Analyzed Economic Effects

4 provisions identified: 3 benefits, 1 costs, 0 mixed.

Voriconazole Test Moved to Class II

The FDA has classified the voriconazole test system as Class II (special controls) effective May 9, 2025 (classification was applicable May 5, 2017). FDA states this classification will reduce regulatory burdens and enhance patients' access to the test by placing it in a lower device class than the automatic Class III assignment.

Enables Use as Predicate for 510(k) Devices

By classifying the device into Class II via the De Novo process, the voriconazole test system can serve as a predicate device that other sponsors may rely on to submit less-burdensome 510(k) premarket notifications rather than De Novo or premarket approval.

Required Validation Studies and Study Details

Manufacturers must meet special controls including design verification and validation with: precision studies using a minimum of three samples at different concentrations (including near medical decision points), method comparison data collected at three laboratory sites with a comparator method not biased by nonspecific detection, interference studies for co-administered medications, and cross-reactivity data for N-oxide voriconazole.

Labeling Must Carry Specific Warning

The device labeling must include the warning statement: "This assay should only be used in conjunction with information available from clinical evaluations and other diagnostic procedures." This labeling requirement is part of the special controls for the voriconazole test system (21 CFR 862.3970(b)(2)).

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Rule Effective
5/9/2025
5/9/2025

Department and Agencies

Department
Independent Agency
Agency
Health and Human Services Department
Food and Drug Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register